Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28283746)

Published in Clin Res Cardiol on March 10, 2017

Authors

Birgid Gonska1, Julia Seeger1, Mirjam Keßler1, Alexander von Keil1, Wolfgang Rottbauer1, Jochen Wöhrle2

Author Affiliations

1: Department of Internal Medicine II-Cardiology, University of Ulm, Ulm, Germany.
2: Department of Internal Medicine II-Cardiology, University of Ulm, Ulm, Germany. jochen.woehrle@uniklinik-ulm.de.

Associated clinical trials:

Prospective Arm of Conduct - Edwards SAPIEN3 PPI Registry (Conduct-pro) | NCT03715894

Articles cited by this

Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med (2010) 22.04

Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation (2002) 8.51

Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med (2016) 6.95

Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med (2012) 4.47

2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.20

Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation (2012) 2.95

Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol (2014) 1.70

Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation (2013) 1.47

Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With the SAPIEN 3 Balloon-Expandable Transcatheter Heart Valve. JACC Cardiovasc Interv (2016) 1.46

Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol (2012) 1.44

Changes in the Pacemaker Rate After Transition From Edwards SAPIEN XT to SAPIEN 3 Transcatheter Aortic Valve Implantation: The Critical Role of Valve Implantation Height. JACC Cardiovasc Interv (2016) 1.44

Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv (2008) 1.35

Calcium distribution patterns of the aortic valve as a risk factor for the need of permanent pacemaker implantation after transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging (2016) 1.09

Clinical impact of a new left bundle branch block following TAVI implantation: 1-year results of the TAVIK cohort. Clin Res Cardiol (2014) 0.97

Incidence and predictors of permanent pacemaker requirement after transcatheter aortic valve implantation with a self-expanding bioprosthesis. Pacing Clin Electrophysiol (2010) 0.93

Cost of transcatheter aortic valve implantation and factors associated with higher hospital stay cost in patients of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Arch Cardiovasc Dis (2013) 0.91

Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve. Int J Cardiol (2015) 0.89

Chronic pacing and adverse outcomes after transcatheter aortic valve implantation. Heart (2015) 0.88

Cause of complete atrioventricular block after percutaneous aortic valve implantation: insights from a necropsy study. Circulation (2009) 0.88

Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J (2013) 0.87

Outcomes following pacemaker implantation after transcatheter aortic valve implantation with CoreValve(®) devices: Results from the FRANCE 2 Registry. Catheter Cardiovasc Interv (2015) 0.86

Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. Eur Heart J (2016) 0.84

Transfemoral aortic valve implantation in pure native aortic valve insufficiency using the repositionable and retrievable lotus valve. Catheter Cardiovasc Interv (2015) 0.80

A revised methodology for aortic-valvar complex calcium quantification for transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging (2014) 0.79

Bicuspid Aortic Stenosis Treated With the Repositionable and Retrievable Lotus Valve. Can J Cardiol (2015) 0.78

Non-contrast-enhanced magnetic resonance angiography is equal to contrast-enhanced multislice computed tomography for correct aortic sizing before transcatheter aortic valve implantation. Clin Res Cardiol (2015) 0.78

Conduction Abnormalities and Pacemaker Implantations After SAPIEN 3 Vs SAPIEN XT Prosthesis Aortic Valve Implantation. Rev Esp Cardiol (Engl Ed) (2015) 0.78

Autopsy finding of the Sapien XT valve from a patient who died suddenly after transcatheter aortic valve replacement. Cardiovasc Interv Ther (2013) 0.77

First experience with the new generation Edwards Sapien 3 aortic bioprosthesis: procedural results and short term outcome. J Interv Cardiol (2015) 0.77

Predictors of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement With the SAPIEN 3. JACC Cardiovasc Interv (2016) 0.77

Clinical significance of conduction disturbances after aortic valve intervention: current evidence. Clin Res Cardiol (2014) 0.76

Impact of left ventricular conduction defect with or without need for permanent right ventricular pacing on functional and clinical recovery after TAVR. Clin Res Cardiol (2015) 0.76

Optimized Implantation Height of the Edwards SAPIEN 3 Valve to Minimize Pacemaker Implantation After TAVI. J Interv Cardiol (2016) 0.75